Skip to main content
. 2016 Mar 17;11(3):e0151608. doi: 10.1371/journal.pone.0151608

Fig 2. Subgroup analyses and meta-analyses show that the MAPF has prognostic value for OS (A), DFS (B) and PRF (C) in patients with GC with negative cytology.

Fig 2

HHS Vulnerability Disclosure